(Q36007863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Advances in diabetes for the millennium: insulin treatment and glucose monitoring (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Daniel Einhorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

16 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

MedGenMed : Medscape general medicine

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15647713%20AND%20SRC:MED&resulttype=core&format=json

Use of implantable insulin pumps: the EVADIAC position. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases). Evaluation dans le Diabete du Traitement par Implants Actifs

7 January 2020

cites work

1 reference

12 December 2020

Detection of hypoglycemia with the GlucoWatch biographer

1 reference

12 December 2020

Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

12 December 2020

Advances toward the implantable artificial pancreas for treatment of diabetes

1 reference

12 December 2020

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps

1 reference

12 December 2020

The human insulin analogue insulin lispro

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors

1 reference

12 December 2020

Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group

1 reference

12 December 2020

A model-based algorithm for blood glucose control in type I diabetic patients.

1 reference

12 December 2020

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime

1 reference

12 December 2020

Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections

1 reference

12 December 2020

Metabolic and immunologic effects of insulin lispro in gestational diabetes

1 reference

12 December 2020

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

1 reference

12 December 2020

Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group

1 reference

12 December 2020

Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

1 reference

12 December 2020

The MiniMed Continuous Glucose Monitoring System (CGMS).

1 reference

12 December 2020

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

1 reference

12 December 2020

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

12 December 2020

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

1 reference

12 December 2020

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabet

1 reference

12 December 2020

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

1 reference

12 December 2020

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group

1 reference

12 December 2020

Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team

1 reference

12 December 2020

Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study

1 reference

12 December 2020

Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study

1 reference

12 December 2020

Dawn phenomenon and Somogyi effect in IDDM.

1 reference

12 December 2020

The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity

1 reference

12 December 2020

A simple insulin infusion algorithm for establishing and maintaining overnight near-normoglycemia in type I and type II diabetes.

1 reference

12 December 2020

The Dawn Phenomenon: Comparison between Normal and Insulin-Dependent Diabetic Adolescents

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Nocturnal blood glucose control in type I diabetes mellitus

1 reference

12 December 2020

The GlucoWatch biographer: a frequent automatic and noninvasive glucose monitor

1 reference

12 December 2020

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

1 reference

12 December 2020

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Continuous subcutaneous glucose monitoring in children with type 1 diabetes

1 reference

12 December 2020

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

1 reference

12 December 2020

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

12 December 2020

Identifiers

1 reference